Actively Recruiting

Phase Not Applicable
Age: 40Years - 60Years
FEMALE
ID07334626

Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy

Led by Benha University · Updated on 2026-01-15

60

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Breast cancer survivors who are receiving hormonal therapy with aromatase inhibitors face a high risk of bone loss and osteoporosis due to lower estrogen levels. This research aims to study whether Pilates exercises can improve bone health in these patients by focusing on bone mineral density (BMD) at the lumbar spine and hip. The study responds to a lack of randomized trials testing Pilates specifically for bone outcomes in this group. The study involves a 12-week Pilates program consisting of mat-based exercises, potentially using light equipment like resistance bands and small weights. Participants will exercise for 60 minutes, three times a week, with sessions guided by a physiotherapist experienced in cancer rehabilitation. Alongside Pilates, all participants will receive daily calcium and vitamin D supplements as part of standard osteoporosis care. The program will gradually increase in difficulty based on each participant's tolerance. Participants will be assessed at the start and after 12 weeks for bone mineral density and quality of life related to breast cancer therapy using questionnaires. They will attend supervised exercise sessions and receive supplementation throughout the study. Researchers will monitor bone health changes and overall functional status during this period. Total participation spans approximately three months, focusing on the effects of Pilates combined with supplements on bone strength and patient well-being.

CONDITIONS

Brief Title

Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy

Who Can Participate

Age: 40Years - 60Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female breast cancer survivors aged 40 to 60 years
  • Histologically confirmed stage I to III breast cancer
  • Currently receiving hormonal therapy (aromatase inhibitors) for at least 3 months
  • At risk of osteoporosis or low bone mineral density with T-score ≤ -1.0 at lumbar spine or hip
  • Medically cleared for low-to-moderate intensity Pilates exercise
  • Able to attend supervised Pilates sessions three times per week for 12 weeks
  • Willing and able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Metastatic (stage IV) or recurrent breast cancer
  • History of osteoporotic fractures within the past 12 months
  • Severe cardiovascular, respiratory, or musculoskeletal conditions that prevent exercise
  • Uncontrolled hypertension, diabetes, or thyroid disorders
  • Current use of corticosteroids
  • Active bone metabolic diseases other than osteoporosis (e.g., Paget's disease, osteomalacia)
  • Severe cognitive impairment or psychiatric illness preventing adherence to exercise or supplementation
  • Known allergy or intolerance to calcium or vitamin D supplements
  • Participation in another clinical trial involving exercise or bone-targeted treatment within the last 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - 12 weeks

Participants engage in a 12-week Pilates exercise program combined with daily calcium and vitamin D supplementation to evaluate effects on bone mineral density.

Three supervised Pilates sessions per week

Trial Site Locations

Total: 1 location

1

Outpatient clinic, faculty of Physical Therapy, Benha university

Banhā, Benha, Egypt, 11603

Actively Recruiting

Loading map...

Research Team

M

Mahmoud Hamada Mohamed Associate Professor, Ph.D

A

Ahmed Mounir Salama Associate Professor, Ph.D

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here